These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8029480)

  • 1. Potassium channel activators: pharmacological methods, models, and structure-activity relationships.
    Evans JM; Taylor SG
    Prog Med Chem; 1994; 31():411-46. PubMed ID: 8029480
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel thieno[2,3-b]- and [3,4-b]pyrans as potassium channel openers. Thiophene systems--XVII.
    Press JB; McNally JJ; Sanfilippo PJ; Addo MF; Loughney D; Giardino E; Katz LB; Falotico R; Haertlein BJ
    Bioorg Med Chem; 1993 Dec; 1(6):423-35. PubMed ID: 8087564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically selective potassium channel openers having 1,1-diethylpropyl group.
    Yoshiizumi K; Seko N; Nishimura N; Ikeda S; Yoshino K; Kondo H; Tanizawa K
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3397-402. PubMed ID: 9873741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
    Tyrrell E; Tesfa KH; Greenwood I; Mann A
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiophene systems. 14. Synthesis and antihypertensive activity of novel 7-(cyclic amido)-6-hydroxythieno[3,2-b]pyrans and related compounds as new potassium channel activators.
    Sanfilippo PJ; McNally JJ; Press JB; Fitzpatrick LJ; Urbanski MJ; Katz LB; Giardino E; Falotico R; Salata J; Moore JB
    J Med Chem; 1992 Nov; 35(23):4425-33. PubMed ID: 1447742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel potassium channel activators: synthesis and structure-activity relationship studies of 3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Matsumoto Y; Tsuzuki R; Matsuhisa A; Takayama K; Yoden T; Uchida W; Asano M; Fujita S; Yanagisawa I; Fujikura T
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):103-14. PubMed ID: 8582029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of trans(+-)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogues: a new class of potassium channel opener.
    Brown TJ; Chapman RF; Cook DC; Hart TW; McLay IM; Jordan R; Mason JS; Palfreyman MN; Walsh RJ; Withnall MT
    J Med Chem; 1992 Oct; 35(20):3613-24. PubMed ID: 1433171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution to the study of the mechanism of action of potassium channel activators].
    Lebrun P
    Bull Mem Acad R Med Belg; 1993; 148(1-2):108-14. PubMed ID: 8111337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,2-Dialkylnaphthalen-1-ones as new potassium channel activators.
    Almansa C; Gómez LA; Cavalcanti FL; Rodríguez R; Carceller E; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1993 Jul; 36(15):2121-33. PubMed ID: 8340916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of N-(6-functionalized-amino-3-pyridyl)-N'-bicycloalkyl-N''-cyanoguanidine s as antihypertensive agents.
    Eda M; Takemoto T; Okada T; Sakashita H; Matzno S; Gohda M; Hayashi K; Nakamura N; Fukaya C
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):307-13. PubMed ID: 8998837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel potassium-channel openers: preparation and pharmacological evaluation of racemic and optically active N-(6-amino-3-pyridyl)-N'-bicycloalkyl-N"-cyanoguanidine derivatives.
    Eda M; Takemoto T; Ono S; Okada T; Kosaka K; Gohda M; Matzno S; Nakamura N; Fukaya C
    J Med Chem; 1994 Jun; 37(13):1983-90. PubMed ID: 8027980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of substituents in 3-position on the activity of chroman-type potassium channel activators.
    Bergmann R; Gericke R
    Arch Pharm (Weinheim); 1994 Mar; 327(3):169-73. PubMed ID: 8179475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of the enantiomers of some potassium channel activators using an alpha 1-acid glycoprotein column.
    Evans JM; Smith RJ; Stemp G
    J Chromatogr; 1992 Oct; 623(1):163-7. PubMed ID: 1452627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR analysis of tautomerisms of active pinacidil-type potassium channel openers and a less active one.
    Yoshiizumi K; Nakajima F; Kiyoi T; Kondo H
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2463-6. PubMed ID: 11078201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K(+)-channel openers: new antihypertensive drugs?
    Haeusler G
    Clin Physiol Biochem; 1990; 8 Suppl 2():46-56. PubMed ID: 2095310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential.
    Longman SD; Hamilton TC
    Med Res Rev; 1992 Mar; 12(2):73-148. PubMed ID: 1535674
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators.
    Bergmann R; Gericke R
    J Med Chem; 1990 Feb; 33(2):492-504. PubMed ID: 2299619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channel openers induce mitochondrial matrix volume changes via activation of ATP-sensitive K+ channel.
    Szewczyk A; Mikołajek B; Pikuła S; Nałecz MJ
    Pol J Pharmacol; 1993; 45(4):437-43. PubMed ID: 8118486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of K+ channel openers.
    Edwards G; Weston AH
    Trends Pharmacol Sci; 1990 Oct; 11(10):417-22. PubMed ID: 2256183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.